Rahmad Akbar

Rahmad Akbar is an antibody designer who has pioneered methods to design antibodies. He established the proof of principle for the machine learning prediction of antibody-antigen binding and the proof of principle of generative design. At Novo Nordisk he operationalizes artificial intelligence (AI) for antibody design by integrating multi-parameter data, building and deploying machine learning oracles and generative AI methods. He envisions antibody for everyone, a vision where highly accessible antibody therapeutics enable people to live the best version of themselves.